Orexo: Zubsolv Rx data and CMD takeaways

Research Update

2018-12-07

12:23

Zubsolv sales continue to grow better than double-digit percentage points (+21% y/y in November). However, the market share ended the month slightly lower by 0.1% compared to October.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.